Skip to content

Role of oral hygiene and yoga in patients with asthma and pyorrhea

Comparative Evaluation of Effects of Yoga and Oral Hygiene Interventions In Asthmatic Patients With Periodontal Diseases: A Randomised Control Trial

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/01/030350
Enrollment
80
Registered
2021-01-08
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J459- Other and unspecified asthma

Interventions

Intervention1: Standard treatment of Asthma(corticosteroids and beta 2 agonist drugs), Yoga, and Scaling & Root planing: All the asthmatic patients with periodontal diseases will be enrolled after ful
SRP), group 4 (Yoga + SRP). A thorough medical and dental history will be taken. Following parameters will be recorded- 1. Plaque index (Sillness and Loe) 2. Gingival index (Loe and Silness) 3. Gingi

Sponsors

King George Medical University
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Asthmatic patients confirmed by latest GINA ( Global Initiate for Asthma) guidelines 2019 2.18-70 years of age 3.Dentulous patients at least 20 teeth with pocket depth less than 5mm with BOP (Bleeding On Probing) 4.No history of periodontal therapy in the last 3 months 5.Patients who will give their written consent

Exclusion criteria

Exclusion criteria: 1. History of Smokers 2. Uncontrolled diabetes, known case of cardiovascular diseases and other comorbidities 3. Pregnant or lactating women 4. Edentulous and mentally disabled patients 5. Inability to perform lung function test 6. Use of any drug known to have an impact on periodontal tissues

Design outcomes

Primary

MeasureTime frame
To assess the spirometric and periodontal parameters in asthmatic patients with periodontal diseases. Also to assess the quality of life.Timepoint: periodontal parameters at baseline,1,3 and 6 months. Spirometric and quality of life at baseline and 6 months

Secondary

MeasureTime frame
To assess the salivary level of interleukin IL-1 beta in asthmatic patients with periodontal diseases.Timepoint: At baseline and 6 months

Countries

India

Contacts

Public ContactDr Umesh Pratap Verma

Faculty of Dental Sciences, King George Medical University

umeshpratapverma@kgmcindia.edu9450195422

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026